It causes early and multifocal onset of estrogen receptor positive hyperplasia that rapidly progresses through a series of well-defined lesions to estrogen receptor negative invasive carcinoma of the luminal molecular subtype [18]. This evidence concerns the gene ESR1 and invasive carcinoma.